Medical devices, healthcare technology and the business of care
PMA approval · P170032

Woven EndoBridge (WEB) Aneurysm Embolization System

Microvention, Inc. · Decision date Dec 31, 2018

MEDTECHLEDGER EXPLANATIONP170032

What did the FDA approve?

The FDA database entry records an original PMA approval for the Woven EndoBridge (WEB) Aneurysm Embolization System, an intrasaccular flow disruption device in the neurology specialty. The approval covers use in adults to embolize saccular intracranial wide neck bifurcation aneurysms in specified anterior and posterior circulation locations, with a dome diameter of 3 mm to 10 mm and a neck size of 4 mm or greater or a dome-to-neck ratio greater than 1 and less than 2.

The decision date is December 31, 2018, and the applicant is MicroVention, Inc. The entry lists no supplement type or supplement reason, so this record does not describe a change to a prior approval. The statement reports the approved scope of use; it does not by itself provide independent proof of safety or clinical effectiveness.

FDA approval order statement

Approval for use in adults to embolize saccular intracranial wide neck bifurcation aneurysms located in the anterior (middle cerebral artery (MCA) bifurcation, internal carotid artery (ICA) terminus, anterior communicating artery (AComm) complex) and posterior (basilar apex) circulations, ranging in size from 3 mm to 10 mm in dome diameter, where the neck size is 4 mm or greater or the dome-to-neck ratio is greater than 1 and less than 2.
Regulatory pathway
Original PMA
Clinical specialty
Neurology
Decision date
Dec 31, 2018

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P170032
Regulatory pathway
Premarket approval application
Product code
OPR
Decision code
APPR
Decision date
Dec 31, 2018
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Intrasaccular Flow Disruption Device.

Product code
OPR
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P170032 received

    Application receipt date recorded by FDA.

  2. P170032 · FDA decision

    APPR

  3. P170032/S024 · Related supplement

    Woven EndoBridge (WEB) Aneurysm Embolization System

Timeline entries are records held by MedtechLedger for P170032. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P170032

Product / regulatory recordCompanyPathwayDecision dateSource
Microvention, Inc.PMA supplementOct 27, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Microvention, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
35 Enterprise, Aliso Viejo, CA, 92656

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records